Results 271 to 280 of about 13,388,827 (299)

DPP-4 Inhibitors: Monotherapy

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects

Expert Opinion on Drug Metabolism and Toxicology, 2016
André Scheen
exaly  

A novel DPP-4 inhibitor teneligliptin scavenges hydroxyl radicals: In vitro study evaluated by electron spin resonance spectroscopy and in vivo study using DPP-4 deficient rats

Metabolism: Clinical and Experimental, 2016
Toshihide Yamasaki, Toyoshi Inoguchi, Noriyuki Sonoda   +2 more
exaly  

Review on Chemistry, Analysis and Pharmacology of Teneligliptin: A Novel DPP-4 Inhibitor

Mini-Reviews in Medicinal Chemistry, 2020
Ketan Vinayakrao Hatware, Kiran Patil, Sanjay Sharma   +2 more
exaly  

Linagliptin: A New DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Postgraduate Medicine, 2011
Peter Paul Toth
exaly  

DPP-4 Inhibitors: An Overview

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

Absorption, metabolism and excretion of [14C]omarigliptin, a once-weekly DPP-4 inhibitor, in humans

Xenobiotica, 2018
Shiyao Xu
exaly  

DPP-4 inhibitor

2014
HAYASHIDA OSAMU, KUSUBATA MASASHI, ATSUZAWA YUJI, TAGA YUKI, KOYAMA YOUICHI, HATTORI SHUNJI   +5 more
openaire   +2 more sources

Sitagliptin (DPP-4 Inhibitor)-induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report

Internal Medicine, 2012
Naoya Igaki
exaly  

Discovery and pharmacological characterization of -[2-({2-[(2)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor

Bioorganic and Medicinal Chemistry, 2011
Mitsuhiro Makino, Motohiro Takeda
exaly